Abstract 2157: Racial Differences in Hospitalizations for Atrial Fibrillation in the United States

Circulation ◽  
2008 ◽  
Vol 118 (suppl_18) ◽  
Author(s):  
Paul B Tabereaux ◽  
Todd M Brown ◽  
Jose Osorio ◽  
G. N Kay ◽  
Dawn M Bravada

Introduction: Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in the United States; however a paucity of population-based data about nonwhite individuals exist. The objectives of this study were to compare hospitalizations among Whites and African Americans (AA) and to determine whether race is an independent predictor of hospitalization for AF in the United States. Methods: Data was obtained from the National Hospital Discharge Survey (years 1996 –2005) and included hospitalizations with a principal diagnosis of AF for patients aged ≥18 yrs and race designated as either White or AA. Codes from the International Classification of Diseases -9th revision were used to define AF (427.31), hypertension (401– 405), ischemic heart disease (410 – 414), diabetes mellitus (250), heart failure (425,428) and valvular heart disease (424). Multivariable analysis with logistic regression was used to identify factors that were independently associated with AF hospitalizations Results: Among 297,962,043 hospitalizations between 1996 –2005, 3,676,787 (1.2%) had a principal diagnosis of AF. Among the hospitalizations for AF, white race was more common than AA race (2,393,659/186,904,962 of whites (1.3% of white’s hospitalized) and 209,788/33,972,665 of African Americans (0.6% of AA’s hospitalized), p<0.0001). After adjusting for the most common risk factors for AF (age, sex, hypertension, ischemic heart disease, diabetes mellitus, heart failure and valvular heart disease) AA race was independently associated with a decreased odds of hospitalizations for AF (Table 1 : adjusted OR=0.49, 95%CI 0.46 – 0.51). Conclusions: After adjusting for the most common risk factors for AF, the odds of hospitalization for AF in AA’s remained half that of whites. Race may be a novel and unaccounted risk factor for atrial fibrillation.

2021 ◽  
Vol 9 (11) ◽  
pp. 521-526
Author(s):  
A. Maliki Alaoui ◽  
◽  
Y. Fihri ◽  
A. Ben El Mekki ◽  
H. Bouzelmat ◽  
...  

Heart failure (HF) is a major public issue taking an epidemic dimension globally. Its incidence is continuing to rise because of a growing and aging population. We held a cross-sectional retrospective studyin the cardiology department of Mohamed V military teaching hospital of Rabat in morocco fromSeptember 2019 toSeptember 2021, including 104 patients admitted with HF. The mean age was 68.5 ±10.3year. Hypertension and diabetes mellitus are the most common risk factors. HF with reduced ejection fraction represents about 49%. Forty-four percent had dilated cardiomyopathy. Ischemic heart disease is the first cause of HF.


Author(s):  
Muhammad Shahzeb Khan ◽  
Pankaj Kumar ◽  
Jayakumar Sreenivasan ◽  
Safi U. Khan ◽  
Khurram Nasir ◽  
...  

2003 ◽  
Vol 8 (1_suppl) ◽  
pp. S13-S26 ◽  
Author(s):  
Bramah N. Singh

Atrial fibrillation is now the most common cardiac arrhythmia for which a patient is hospitalized. Clinically, it presents in a form that is paroxysmal, persistent, or permanent and may be symptomatic or asymptomatic, occurring in the setting of either no cardiac disease (“lone atrial fibrillation”) or, most often, in association with an underlying disease. Atrial fibrillation is associated with a 2-fold increase in mortality and, in the United States alone, causes over 75,000 cases of stroke per year. The annual prevalence of stroke is 5% to 7%, but the use of adequate anticoagulation can reduce this to less than 1%. Atrial fibrillation is a disorder of the elderly, with almost equal prevalence in men and women. In the United States, 80% of atrial fibrillation occurs in patients over the age of 65 years, and its prevalence tracks that of heart failure, which may be the cause, as well as the result, of the arrhythmia. Both conditions are increasing in epidemic proportions in the aging population. The most common causes of atrial fibrillation are hypertensive heart disease, coronary artery disease, and heart failure with a miscellany of lesser conditions, with about 10% lacking structural heart disease. Unlike other supraventricular arrhythmias, cure by the use of catheter ablation and surgical techniques has not been a reality except in a relatively small number of cases. However, restoration and maintenance of sinus rhythm remain the initial goal of therapy for most patients. Pharmacologic approaches remain the mainstay of therapy for rate control and anticoagulation as well as for maintenance of sinus rhythm following pharmacological or electrical conversion. The changing epidemiology of atrial fibrillation is highlighted, with the focus on its conversion by the use of newer and novel antifibrillatory agents relative to the mechanisms of the arrhythmia, to restore the stability of sinus rhythm.


EDIS ◽  
2021 ◽  
Vol 2021 (1) ◽  
pp. 8
Author(s):  
Elena B. Smith ◽  
Jodi Fitzgerald ◽  
Danielle Nelson ◽  
Madison Woodard ◽  
Jeanette Andrade

Heart disease is the #1 cause of death among men and women within the United States.  Heart disease is an umbrella term for the following heart conditions: Angina Irregular heartbeats Heart attacks Heart failure Stroke This new 8-page publication of the UF/IFAS Food Science and Human Nutrition Department describes the modifiable risk factors for heart disease and tips to reduce one’s risk for heart disease. Written by Elena B. Smith, Jodi Fitzgerald, Danielle Nelson, Madison Woodard, and Jeanette Andrade.https://edis.ifas.ufl.edu/fs426


2020 ◽  
Vol 13 (Suppl_1) ◽  
Author(s):  
Vibhu Parcha ◽  
Rajat Kalra ◽  
Nirav Patel ◽  
Thomas J Wang ◽  
Garima Arora ◽  
...  

Introduction: Improvements in therapy and prevention have led to declining cardiovascular mortality in the United States, but it is not clear whether these improvements have narrowed geographic disparities in cardiovascular outcomes. We sought to compare mortality due to cardiovascular disease, heart failure, stroke, and ischemic heart disease in the stroke belt cluster of 11 states versus the rest of the United States. Methods: A retrospective cross-sectional analysis of the CDC WONDER database was done to evaluate the nationwide mortality trends derived from the death certificates of all American residents from 1999 to 2017. Mortality trends for death due to heart failure, stroke, ischemic heart disease or any cardiovascular cause, were identified in the stroke belt and non-stroke belt populations using ICD-10 codes. Piecewise linear regression was used to assess the change in mortality trends. Results: Among 16,111,775 deaths due to cardiovascular causes during the study period, the age-adjusted mortality rates (AAMR) were highest among non-Hispanic Black, males from non-metropolitan areas, living in the stroke belt. In the stroke belt, AAMR due to all cardiovascular causes [Average Annual Percentage Change (AAPC): -2.5 (95% CI:-2.9 to -2.0); p<0.001], stroke [AAPC: -2.9 (95% CI: -3.7 to -2.1); p<0.001] and ischemic heart disease [AAPC: -3.9 (95% CI: -4.3 to -3.5); p<0.001] declined from 1999 to 2017. Similarly, a decrease in cardiovascular [AAPC: -2.6 (95% CI:-3.1 to -2.1); p<0.001], stroke [AAPC:-2.9 (95% CI: -3.2 to -2.2); p<0.001] and ischemic heart disease [AAPC: -4.1 (95% CI: -4.5 to -3.6); p<0.001] mortality was seen in the non-stroke belt region from 1999 to 2017. There was no overall change in heart failure mortality in either regions (p for AAPC >0.05). The gap in age-adjusted mortality estimates for cardiovascular cause of death was 11.8% in 1999 and was 16% in 2017 across the two regions ( Figure 1 ). The mortality gaps were persistent across sub-groups of age, sex, race, and level of urbanization. Conclusions: Despite the overall decline in cardiovascular mortality, significant geographic disparities in cardiovascular mortality persist. Preventive efforts targeting risk factors and improved disease management may attenuate the longstanding geographical heterogeneity in cardiovascular mortality.


Sign in / Sign up

Export Citation Format

Share Document